The historical rank and industry rank for Seikagaku's EV-to-EBIT or its related term are showing as below:
TSE:4548'
s EV-to-EBIT Range Over the Past 10 Years
Min: -103.51 Med: 13.27 Max: 63.97
Current: 8.97
During the past 13 years, the highest EV-to-EBIT of Seikagaku was 63.97. The lowest was -103.51. And the median was 13.27.
TSE:4548's EV-to-EBIT is ranked better than 80.35% of 458
companies
in the Medical Devices & Instruments industry
Industry Median: 19.425
vs TSE:4548: 8.97
The historical data trend for Seikagaku's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Seikagaku's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seikagaku's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seikagaku's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Seikagaku's EV-to-EBIT falls into.
Seikagaku's current Enterprise Value is 円15,218 Mil.
Seikagaku's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,695 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seikagaku (TSE:4548) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Seikagaku's Enterprise Value for the quarter that ended in Sep. 2024 was 円26,516 Mil.
Seikagaku's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,695 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seikagaku EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Seikagaku's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4548 has been successfully added to your 